17-Nov-2026 08:30:08
FREDUNGeneral news
FREDUN PHARMACEUTICALS Q2 FY27 CONCALL: EXPECTS TO EXCEED ₹800 CR FY27 REVENUE TARGET; GUIDES 65–70% NEW-AGE BUSINESS GROWTH, 15–20% LEGACY GROWTH & CATICO LAUNCH BY JANUARY 2027
FREDUN PHARMACEUTICALS L
17-Nov-2026 08:30:08
FREDUN PHARMACEUTICALS L